University of Texas Health Science Center at Tyler Pulmonary Disease and Critical Care Medicine

Topics

• Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 8
• Mechanical Circulatory Support Devices 3
• Mycobacterium research and diagnosis 3
• Cancer Immunotherapy and Biomarkers 2
• Chronic Obstructive Pulmonary Disease (COPD) Research 2
• Extracellular vesicles in disease 2
• Lung Cancer Diagnosis and Treatment 2
• Protease and Inhibitor Mechanisms 2
• Telomeres, Telomerase, and Senescence 2
• Ultrasound in Clinical Applications 2
• Advanced Breast Cancer Therapies 1
• Antibiotics Pharmacokinetics and Efficacy 1

Most cited

1. Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment.

   BMC pulmonary medicine · 2023 · 35 citations · Taylor Teague

2. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.

   JAMA internal medicine · 2022 · 75 citations · Megan Devine

3. Inhaled alpha-1 antitrypsin (AAT) restores lower respiratory tract protease-antiprotease homoeostasis and reduces inflammation in AAT-deficient individuals: a randomised phase 2 study.

   ERJ open research · 2025 · 13 citations · Megan Devine

4. Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis.

   Respiratory research · 2022 · 37 citations · Taylor Teague

5. Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency.

   The European respiratory journal · 2025 · 10 citations · Megan Devine

6. ECMO Long Haulers: A Distinct Phenotype of COVID-19-Associated ARDS With Implications for Lung Transplant Candidacy.

   Transplantation · 2022 · 17 citations · Matthew Leveno